{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:22:58Z","timestamp":1778653378856,"version":"3.51.4"},"reference-count":1,"publisher":"BMJ","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"abstract":"<jats:title>The study<\/jats:title><jats:p>Tesfaye S, Sloan G, Petrie J, et al. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.<jats:italic>Lancet<\/jats:italic>2022;400:680-90.<\/jats:p><jats:p>To read the full NIHR Alert, go to:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/evidence.nihr.ac.uk\/alert\/combination-therapy-for-painful-diabetic-neuropathy-is-safe-and-effective\/\">https:\/\/evidence.nihr.ac.uk\/alert\/combination-therapy-for-painful-diabetic-neuropathy-is-safe-and-effective\/<\/jats:ext-link><\/jats:p>","DOI":"10.1136\/bmj.p866","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T11:25:13Z","timestamp":1682076313000},"page":"p866","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Combination therapy for painful diabetic neuropathy is safe and effective"],"prefix":"10.1136","author":[{"given":"Helen","family":"Saul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Deeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candace","family":"Imison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"2023050509554220000_381.apr21_3.p866.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/RXUO6757","article-title":"Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT","volume":"16","author":"Tesfaye","year":"2022","journal-title":"Health Technol Assess"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.p866","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.p866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:55:48Z","timestamp":1683305748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.p866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":1,"alternative-id":["10.1136\/bmj.p866"],"URL":"https:\/\/doi.org\/10.1136\/bmj.p866","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]}}}